MedTrace Logo

Clinical Study of Jianfei Kangfu Cao in the Treatment of pSS-ILD

NCT04544722 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 138

Last updated 2021-03-01

No results posted yet for this study

Summary

This study will evaluate the safety and efficacy of Jianfei Kangfu Cao in the treatment of primary Sjogren's syndrome associated interstitial lung disease.

Conditions

Interventions

BEHAVIORAL

Jianfei Kangfu Cao

The original treatment and Jianfei Kangfu Cao, once a day, 30 minutes each time.

BEHAVIORAL

lung rehabilitation training

The original treatment and the lung rehabilitation training, once a day, 30 minutes each time.

Sponsors & Collaborators

  • Shanghai University of Traditional Chinese Medicine

    lead OTHER

Principal Investigators

  • Zhujing Zhu, Ph.D · Longhua Hospital

  • Jianchun Mao, Master · Longhua Hospital

  • Huanru Qu, Ph.D · Longhua Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-01
Primary Completion
2022-09-01
Completion
2023-06-01

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04544722 on ClinicalTrials.gov